← FDA Drug Approvals (Drugs@FDA)
LENVATINIB
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SUN PHARM INDS INC · Approved 2022-03-01
Drug application
- FDA Application #
ANDA213092- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- LENVATINIB
- Generic name
- Lenvatinib Mesylate
- Active ingredients
- LENVATINIB MESYLATE
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- SUN PHARM INDS INC
- First approval
- 2022-03-01
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown